Plus, the 36-month beta value for BSX is at 0.95. Real time Boston Scientific (BSX) stock price quote, stock graph, news & analysis. The company’s stock price... Union Pacific Corporation (NYSE:UNP) went up by 1.95% from its latest closing price compared to the recent 1-year high of $208.82. Copyright © 2018. The total capital return value is set at 8.56, while invested capital returns managed to touch 25.91. Fitzgerald Joseph Michael, the EVP & Pres, Interven Cardio of Boston Scientific Corporation, sale 77,640 shares at $40.76 during a trade that took place back on Sep 11, which means that Fitzgerald Joseph Michael is holding 221,048 shares at $3,164,653 based on the most recent closing price. This product is for educational purposes only. Disclaimer: Past performance is no guarantee of future performance. Where Does Owens & Minor, Inc. (OMI) Stock Fall in the Medical Distribution Field? The average price target is $45.647, which means analysts expect the stock to increase by 18.13% over the next twelve months. TTD View Boston Scientific Corporation BSX investment & stock information. Stock Price data may be delayed up to 15 minutes. Start a 14-day free trial to Morningstar Premium to unlock our take on BSX. The risk involved with trading stocks, options and other securities is not suitable for all investors. After this action, Pierce David A now owns 2,690 shares of Boston Scientific Corporation, valued at $87,994 using the latest closing price. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. The company’s stock... TherapeuticsMD Inc. (NASDAQ:TXMD) went up by 1.87% from its latest closing price compared to the recent 1-year high of $4.00. The company’s stock price... Livongo Health Inc. (NASDAQ:LVGO) went down by -2.38% from its latest closing price compared to the recent 1-year high of $151.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.97. The content on any of Financhill websites, products or communication is for educational purposes only. We Know the Answer, Union Pacific Corporation (UNP) upgraded Issued by Wall Street Gurus, Range Resources Corporation (RRC) and the Battle of Fundamentals vs. Technicals. Splunk Inc. (SPLK): Skating on Thin Ice? None of the information presented should be construed as an offer to sell or buy any particular security. Wall Street analysts are rating BSX a Strong Buy today. Wall Street is positive on Boston Scientific Corporation (BSX). VRTX Click Here to get the full report on Boston Scientific Corporation (BSX) Stock. According to ratings assigned by 27 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 4 of them are recommending Boston Scientific Corporation (BSX) as a Hold, while 21 are in view that stock is a Buy. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. The Financhill.com educational training program and software services are provided to improve financial understanding. The risk of loss in trading securities can be substantial. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. REPL What our community thinks about Boston Scientific. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. During the last 5 trading sessions, BSX rose by +5.39%, which changed the moving average for the period of 200-days by -10.46% in comparison to the 20-day moving average, which settled at $39.01. Barron’s reported 8 hours ago that A Medical-Device Stock Falls Below Its IPO Price, Boston Scientific Corporation (NYSE:BSX) scored a price-to-earnings ratio above its average ratio, recording 14.38 x from its present earnings ratio. Portfolio results are unaudited and based on varying investment expiration dates. The consensus among analysts is that Boston Scientific Corporation (BSX) is a Buy stock at the moment, with a recommendation rating of 1.7. Scan for stocks set to soar and crash based on powerful seasonal trends plus view the stock … Exact Sciences Corporation (NASDAQ:EXAS) went down by -0.85% from its latest closing price compared to the recent 1-year high of $110.74. On average, analysts give the stock a Strong Buy rating. Based on Boston Scientific Corporation (BSX), the company’s capital structure generated 74.59 points at debt to equity in total, while total debt to capital is 42.72. Opinions of the stock are interesting as 21 analysts out of 27 who provided ratings for Boston Scientific Corporation declared the stock was a “buy,” while 1 rated the stock as “overweight,” 4 rated it as “hold,” and 0 as “sell.”. Total debt to assets is 33.87, with long-term debt to equity ratio resting at 63.90. An overall objective rating for Boston Scientific Corporation (BSX) optimized for predictive value. Proprietary Stock Score Ratings. 4 out of 27 have rated it as a Hold, with 21 advising it as a Buy. InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages.
Dna Motoring Turbo,
Hilo Library Card,
Mere Raja Ki,
Rapunzel Hair Growth,
Trade Windows Near Me,
Dabney S Lancaster Community College Directory,
Asparagus Parmesan Lemon Soup,
Statistically Do Second Babies Come Early,
S2000 J's Racing Exhaust,
Cornell University Campus,
Mdf Door Price Philippines,